AK

Abhimanyu Kumar

Active Director Director DIN 08713034
DIN 08713034 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value •••• Premium profile

About Abhimanyu Kumar

Data last updated:

Abhimanyu Kumar is a Director at Mebita Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Mebita Pharmaceutical Private Limited reported revenue of ₹7.91 Cr (FY 2025).

DIN 08713034
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2020
Oldest Company Age 7 yrs
Largest company Mebita Pharmaceutical Private Limited · ₹7.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20202019₹7.91 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Mebita Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Abhimanyu Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhimanyu Kumar

Abhimanyu Kumar currently holds 1 directorship: Mebita Pharmaceutical Private Limited (Director, since 28 Feb 2020, revenue ₹7.91 Cr (FY 2025)).

Abhimanyu Kumar was first appointed on 28 Feb 2020 as Director at Mebita Pharmaceutical Private Limited.

The current boards of Abhimanyu Kumar's companies include Narendra Nath Thakur (Mebita Pharmaceutical Private Limited), Nikhil Ranjan (Mebita Pharmaceutical Private Limited), Rupesh Kumar (Mebita Pharmaceutical Private Limited), Vanibhushan (Mebita Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available